相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rho Kinase Inhibition as a Therapeutic for Progressive Supranuclear Palsy and Corticobasal Degeneration
Erik G. Gentry et al.
JOURNAL OF NEUROSCIENCE (2016)
Assessment of disease-related cognitive impairments using the novel object recognition (NOR) task in rodents
Ben Grayson et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Water Dispersion Interactions Strongly Influence Simulated Structural Properties of Disordered Protein States
Stefano Piana et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2015)
AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson's disease in vitro and in vivo
Kim-Ann Saal et al.
NEUROBIOLOGY OF DISEASE (2015)
Olfactory Dysfunction and Neurotransmitter Disturbance in Olfactory Bulb of Transgenic Mice Expressing Human A53T Mutant α-Synuclein
Sufang Zhang et al.
PLOS ONE (2015)
The Interplay between Alpha-Synuclein Clearance and Spreading
Tomas Lopes da Fonseca et al.
BIOMOLECULES (2015)
Rho Kinase Inhibition Modulates Microglia Activation and Improves Survival in a Model of Amyotrophic Lateral Sclerosis
Lars Toenges et al.
GLIA (2014)
Rho Kinase Inhibition by Fasudil in the Striatal 6-Hydroxydopamine Lesion Mouse Model of Parkinson Disease
Lars Tatenhorst et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2014)
Evaluation of Rho-Kinase Activity in Mice Brain Using N-[11C]Methyl-hydroxyfasudil with Positron Emission Tomography
Junko Taniguchi et al.
MOLECULAR IMAGING AND BIOLOGY (2014)
The neurobiological basis of cognitive impairment in Parkinson's disease
Glenda M. Halliday et al.
MOVEMENT DISORDERS (2014)
Chemical con artists foil drug discovery
Jonathan Baell et al.
NATURE (2014)
Inhibition of the microglial response is essential for the neuroprotective effects of Rho-kinase inhibitors on MPTP-induced dopaminergic cell death
Ana Borrajo et al.
NEUROPHARMACOLOGY (2014)
ROCK2 is a major regulator of axonal degeneration, neuronal death and axonal regeneration in the CNS
J. C. Koch et al.
CELL DEATH & DISEASE (2014)
Systematic Comparison of the Effects of Alpha-synuclein Mutations on Its Oligomerization and Aggregation
Diana F. Lazaro et al.
PLOS GENETICS (2014)
Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease
Jens Wagner et al.
ACTA NEUROPATHOLOGICA (2013)
The many faces of alpha-synuclein: from structure and toxicity to therapeutic target
Hilal A. Lashuel et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Behavioral Characterization of A53T Mice Reveals Early and Late Stage Deficits Related to Parkinson's Disease
Katrina L. Paumier et al.
PLOS ONE (2013)
Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease
Lars Toenges et al.
BRAIN (2012)
Cognitive deficits in a mouse model of pre-manifest Parkinson's disease
Iddo Magen et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2012)
Different 8-Hydroxyquinolines Protect Models of TDP-43 Protein, α-Synuclein, and Polyglutamine Proteotoxicity through Distinct Mechanisms
Daniel F. Tardiff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Curcumin Prevents Aggregation in α-Synuclein by Increasing Reconfiguration Rate
Basir Ahmad et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Identifying prodromal Parkinson's disease: Pre-Motor disorders in Parkinson's disease
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2012)
Involvement of microglial RhoA/Rho-Kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors
Begona Villar-Cheda et al.
NEUROBIOLOGY OF DISEASE (2012)
Use of viral vectors to create animal models for Parkinson's disease
Karin Loew et al.
NEUROBIOLOGY OF DISEASE (2012)
Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models
L. Lyon et al.
PSYCHOPHARMACOLOGY (2012)
ROCK/Cdc42-mediated microglial motility and gliapse formation lead to phagocytosis of degenerating dopaminergic neurons in vivo
Carlos Barcia et al.
SCIENTIFIC REPORTS (2012)
Role of C-terminal negative charges and tyrosine residues in fibril formation of α-synuclein
Yasutaka Izawa et al.
BRAIN AND BEHAVIOR (2012)
Conserved C-Terminal Charge Exerts a Profound Influence on the Aggregation Rate of α-Synuclein
Katerina Levitan et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Population-based case-control study of cognitive function in early Parkinson's disease (NEDICES)
Julian Benito-Leon et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Ventricular Enlargement and Mild Cognitive Impairment in Early Parkinson's Disease
Turi O. Dalaker et al.
MOVEMENT DISORDERS (2011)
ROCKing regeneration: Rho kinase inhibition as molecular target for neurorestoration
Lars Toenges et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2011)
Automated quantitative gait analysis in animal models of movement disorders
Caroline Vandeputte et al.
BMC NEUROSCIENCE (2010)
Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models
Linhui Julie Su et al.
DISEASE MODELS & MECHANISMS (2010)
Y-27632 improves rotarod performance and reduces huntingtin levels in R6/2 mice
Mei Li et al.
NEUROBIOLOGY OF DISEASE (2009)
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Dagmar E. Ehrnhoefer et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Clinical chemistry reference database for Wistar rats and C57/BL6 mice
Olaf Boehm et al.
BIOLOGICAL CHEMISTRY (2007)
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
E. R. Dorsey et al.
NEUROLOGY (2007)
The dopaminergic midbrain participates in human episodic memory formation:: Evidence from genetic imaging
BH Schott et al.
JOURNAL OF NEUROSCIENCE (2006)
Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory'
Rick A. Bevins et al.
NATURE PROTOCOLS (2006)
A precipitating role for truncated α-synuclein and the proteasome in α-synuclein aggregation -: Implications for pathogenesis of Parkinson disease
CW Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The hippocampal-VTA loop: Controlling the entry of information into long-term memory
JE Lisman et al.
NEURON (2005)
The CCPN data model for NMR spectroscopy: Development of a software pipeline
WF Vranken et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2005)
Rho kinase, a promising drug target for neurological disorders
BK Mueller et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Aggregation promoting C-terminal truncation of α-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations
WX Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Reward-related fMRI activation of dopaminergic midbrain is associated with enhanced hippocampus-dependent long-term memory formation
BC Wittmann et al.
NEURON (2005)
Impact of the acidic C-terminal region comprising amino acids 109-140 on α-synuclein aggregation in vitro
W Hoyer et al.
BIOCHEMISTRY (2004)
Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Aβ42 by inhibiting Rho
Y Zhou et al.
SCIENCE (2003)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation
S Gispert et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2003)
Motor dysfunction and gliosis with preserved dopaminergic markers in human α-synuclein A30P transgenic mice
T Gomez-Isla et al.
NEUROBIOLOGY OF AGING (2003)
Dependence of α-synuclein aggregate morphology on solution conditions
W Hoyer et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53→Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice
MK Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Neuronal α-synucleinopathy with severe movement disorder in mice expressing A53T human α-synuclein
BI Giasson et al.
NEURON (2002)
Comparative analysis of the gait disorder of normal pressure hydrocephalus and Parkinson's disease
H Stolze et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons
PJ McLean et al.
NEUROSCIENCE (2001)
Stride length regulation in Parkinson's disease: the use of extrinsic, visual cues
GN Lewis et al.
BRAIN (2000)
分享论文
